Barnaby Edward Young
Overview
Explore the profile of Barnaby Edward Young including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
3844
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mourad A, Grandits G, Siegel L, Engen N, Barkauskas C, Eriobu N, et al.
Clin Microbiol Infect
. 2025 Feb;
PMID: 39922466
Objectives: Passive immunotherapy, including monoclonal antibodies and neutralizing proteins, was used for the treatment of patients with COVID-19 during the pandemic. Accelerating COVID-19 Therapeutic Interventions and Vaccines-Therapeutics for Inpatients with...
2.
Han S, Mo Y, Wang L, Lye D, Young B, Paterson D, et al.
IJID Reg
. 2024 Dec;
14:100494.
PMID: 39737414
The COVID-19 pandemic highlighted the critical need for well-established clinical research networks capable of rapid response during infectious disease outbreaks. In Southeast Asia, the absence of active research networks at...
3.
Wee L, Lim J, Tay A, Chiew C, Young B, Wong B, et al.
Clin Microbiol Infect
. 2024 Oct;
31(1):139-140.
PMID: 39389464
No abstract available.
4.
Wee L, Lim J, Tay A, Chiew C, Young B, Wong B, et al.
Clin Microbiol Infect
. 2024 Aug;
31(1):93-100.
PMID: 39214187
Objectives: Significant heterogeneity has been reported in cohort studies evaluating the impact of early oral antiviral treatment on preventing postacute sequelae after COVID-19. We evaluated the impact of early nirmatrelvir/ritonavir...
5.
Goh Y, Fong S, Hor P, Loh C, Tay M, Wang B, et al.
Int J Infect Dis
. 2024 Jun;
146:107147.
PMID: 38945433
Objectives: The emergence of new SARS-CoV-2 variants has led to the development of Omicron-targeting bivalent mRNA vaccines. It is crucial to understand how bivalent vaccines may improve antibody responses against...
6.
Ng D, Chia T, Young B, Sadarangani S, Puah S, Low J, et al.
BMC Infect Dis
. 2024 Jan;
24(1):123.
PMID: 38262970
Background: Community-acquired respiratory infections are a leading cause of illness and death globally. The aetiologies of community-acquired pneumonia remain poorly defined. The RESPIRO study is an ongoing prospective observational cohort...
7.
Goh Y, Fong S, Tay M, Rouers A, Chang Z, Chavatte J, et al.
Sci Rep
. 2024 Jan;
14(1):1492.
PMID: 38233454
No abstract available.
8.
Goh Y, Fong S, Hor P, Loh C, Wang B, Salleh S, et al.
J Infect Dis
. 2023 Nov;
230(2):e287-e291.
PMID: 37996071
Background: The emergence of rapidly evolving severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, coupled with waning vaccine-induced immunity, has contributed to the rise of vaccine breakthrough infections. It is...
9.
Goh Y, Fong S, Tay M, Rouers A, Chang Z, Chavatte J, et al.
Sci Rep
. 2023 Nov;
13(1):19331.
PMID: 37935965
Identification of the risk factors and the high-risk groups which are most vulnerable is critical in COVID-19 disease management at a population level. Evaluating the efficacy of vaccination against infections...
10.
Fan B, Mucheli S, Tang Y, Yong E, Dalan R, Cheung C, et al.
Semin Thromb Hemost
. 2023 Sep;
50(4):660-663.
PMID: 37748516
No abstract available.